Cargando…
Exploring the transcriptome of hormone-naive multifocal prostate cancer and matched lymph node metastases
BACKGROUND: The current inability to predict whether a primary prostate cancer (PC) will progress to metastatic disease leads to overtreatment of indolent PCs as well as undertreatment of aggressive PCs. Here, we explored the transcriptional changes associated with metastatic progression of multifoc...
Autores principales: | Schmidt, Linnéa, Møller, Mia, Haldrup, Christa, Strand, Siri H., Vang, Søren, Hedegaard, Jakob, Høyer, Søren, Borre, Michael, Ørntoft, Torben, Sørensen, Karina Dalsgaard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288156/ https://www.ncbi.nlm.nih.gov/pubmed/30449885 http://dx.doi.org/10.1038/s41416-018-0321-5 |
Ejemplares similares
-
Heterogeneous patterns of DNA methylation-based field effects in histologically normal prostate tissue from cancer patients
por: Møller, Mia, et al.
Publicado: (2017) -
RHCG and TCAF1 promoter hypermethylation predicts biochemical recurrence in prostate cancer patients treated by radical prostatectomy
por: Strand, Siri H., et al.
Publicado: (2016) -
Biomarker potential of ST6GALNAC3 and ZNF660 promoter hypermethylation in prostate cancer tissue and liquid biopsies
por: Haldrup, Christa, et al.
Publicado: (2018) -
High levels of 5-hydroxymethylcytosine (5hmC) is an adverse predictor of biochemical recurrence after prostatectomy in ERG-negative prostate cancer
por: Strand, Siri H., et al.
Publicado: (2015) -
Novel diagnostic and prognostic classifiers for prostate cancer identified by genome-wide microRNA profiling
por: Kristensen, Helle, et al.
Publicado: (2016)